Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease.
[A new mouse model of coeliac disease with villous atrophy].
Percentage of Studies Presented at a Conference Prior to Publication in Emergency Medicine Journals.
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. N Engl J Med. 2023 Oct 26; 389(17):1553-1565.
View in:
PubMed
subject areas
Amyloidosis
Amyloidosis, Familial
Cardiomyopathies
Double-Blind Method
Humans
Liver
Prealbumin
RNA, Small Interfering
authors with profiles
Nitasha Sarswat